Filing Details
- Accession Number:
- 0001209191-18-039348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-22 21:35:21
- Reporting Period:
- 2018-06-21
- Accepted Time:
- 2018-06-22 21:35:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 818033 | Heron Therapeutics Inc. | HRTX | Pharmaceutical Preparations (2834) | 942875566 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1384243 | D Barry Quart | 4242 Campus Point Court Suite 200 San Diego CA 92121 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-30 | 1,607 | $13.22 | 69,600 | No | 5 | J | Direct | |
| Common Stock | Acquisiton | 2018-06-21 | 50,000 | $9.05 | 119,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-21 | 50,000 | $39.05 | 69,600 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | J | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-06-21 | 50,000 | $0.00 | 50,000 | $9.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 250,000 | 2024-12-12 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2018.
- The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan executed in December 2017.
- The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (12/12/2014).
Billionaire Hedge Funds
